FDA Recall Terminated Historical recordClass II
Sermorelin/GHRP-2 9 mg-6 mg Powder, Pharm D Solutions, Houston, Texas --- NDC 69699-1728-10
- Reason
- Lack of Assurance of Sterility
- Published
- November 7, 2018
- Distribution
- Nationwide
Data Explorer
Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.
Recall totals
All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.
37,118
Total recall recordsAll FDA and USDA recalls in Public Health Trace9,793
Class I recallsReasonable probability of serious health consequences24,343
Class II recallsTemporary or medically reversible health consequences2,887
Class III recallsNot likely to cause adverse health consequencesQuick insights
A snapshot of the most notable patterns across all recorded FDA and USDA recalls.
Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap.
53 recalls
Most common hazardLack of Assurance of Sterility
2,072 recalls
Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/gf-blends-recalls-truly-aip-all-purpose-flour-and-bread-mix-and-eat-gangster-flat-bread-pizza-mixPublished September 18, 2026
Download matching recalls as CSV
CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.
Filters
Metric
View
A chart of recalls grouped by month.
Download CSVSummary (Year to date)
- 1,527 recalls have been announced year to date.
- Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
- The highest complete period was Jun 2026 (297).
- Sep 2026 is incomplete and not included in the figures above.
- Complete data
- Incomplete
A bar chart of the total number of recalls in this dataset by recall class.
| Class | Recalls |
|---|---|
| Class II | 24,343 |
| Class I | 9,793 |
| Class III | 2,887 |
| Not Yet Classified | 1 |
| Class | Recalls |
|---|---|
| Class II | 24,343 |
| Class I | 9,793 |
| Class III | 2,887 |
| Not Yet Classified | 1 |
FDA Recall Terminated Historical recordClass II
Sermorelin/GHRP-2 18 mg/6 mg powder, Pharm D Solutions, Houston, Texas --- NDC 69699-1748-10
- Reason
- Lack of Assurance of Sterility
- Published
- November 7, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Sermorelin/GHRP-2 6 mg/6 mg Powder, Pharm D Solutions, Houston, Texas --- NDC 69699-1727-10
- Reason
- Lack of Assurance of Sterility
- Published
- November 7, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Sermorelin/Ipamorelin 18 mg/15 mg Powder, Pharm D Solutions, Houston, Texas --- NDC 69699-1759-18
- Reason
- Lack of Assurance of Sterility
- Published
- November 7, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Reck Injection, Pharm D Solutions, Houston, Texas --- NDC 69699-1459-50
- Reason
- Lack of Assurance of Sterility
- Published
- November 7, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
QM-4A Quadmix 5 mL 30 PA-2PH-150A-Atropine 0.4 mg Aqueous Solution, Pharm D Solutions, Houston, Texas --- NDC 69699-1342-05
- Reason
- Lack of Assurance of Sterility
- Published
- November 7, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Pyridoxine 100 mg/mL, 30 mL MDV Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1614-30
- Reason
- Lack of Assurance of Sterility
- Published
- November 7, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Prostaglandin E1 80 mcg/mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1337-05
- Reason
- Lack of Assurance of Sterility
- Published
- November 7, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Prostaglandin E1 40 mcg/mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1347-05
- Reason
- Lack of Assurance of Sterility
- Published
- November 7, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Prostaglandin E1 150 mcg/mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1623-05
- Reason
- Lack of Assurance of Sterility
- Published
- November 7, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Phosphate Buffer Solution 0.05 m Aqueous Solution, Pharm D Solutions, Houston, Texas --- NDC 69699-0912-20
- Reason
- Lack of Assurance of Sterility
- Published
- November 7, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Phenol 7% and Glycerin Aqueous Solution 10 mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1432-10
- Reason
- Lack of Assurance of Sterility
- Published
- November 7, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Phenol 5% and Glycerin Aqueous Solution 10 mL Injection, Pharm D Solutions, Houston, Texas --- NDC 69699-1431-10
- Reason
- Lack of Assurance of Sterility
- Published
- November 7, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Oxytocin 30 unit in LR 500 mL 0.06 units/mL IV,Pharm D Solutions, Houston, Texas --- NDC 69699-1203-50
- Reason
- Lack of Assurance of Sterility
- Published
- November 7, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Methylcobalamin 1 mg/mL a) 10 mL Injectable NDC 69699-1501-10; b) 30 mL Injectable NDC 69699-1501-30, Pharm D Solutions, Houston, Texas
- Reason
- Lack of Assurance of Sterility
- Published
- November 7, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Magnesium 40 gm/ns 1000 mL IV, Pharm D Solutions, Houston, Texas --- NDC 69699-0904-10
- Reason
- Lack of Assurance of Sterility
- Published
- November 7, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Lipo MIC-12 Compound Injectable a) NDC 69699-1603-10; b) 30 mL Stock Solution Compound Injectable NDC 69699-1603-30, Pharm D Solutions, Houston, Texas
- Reason
- Lack of Assurance of Sterility
- Published
- November 7, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Levocarnitine 170 mg/mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1617-10
- Reason
- Lack of Assurance of Sterility
- Published
- November 7, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
HCG 6000 unit/0.3 gm Mannitol Lyopholized 6000 IU/vial injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1739-06
- Reason
- Lack of Assurance of Sterility
- Published
- November 7, 2018
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
HCG 50,000 unit/0.3 gm Mannitol Lyophilized Powder Pharm D Solutions, Houston, Texas --- NDC 69699-1736-50
- Reason
- Lack of Assurance of Sterility
- Published
- November 7, 2018
- Distribution
- Nationwide
Data last updated:
Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.
